The first prospective, double-blind, randomized controlled study of acetylcysteine for the treatment of patients with non-acetaminophen-induced acute liver failure supports its use in patients in the early stages of liver failure. Emergency liver transplantation still has a fundamental role in the management of patients with the most severe form of this syndrome.
References
Prescott, L. F. et al. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. BMJ ii, 1097–1100 (1979).
Harrison, P. M., Keays, R., Bray, G. P., Alexander, G. J. M. & Williams, R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 335, 1572–1573 (1990).
Keays, R. et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ 303, 1026–1029 (1991).
Harrison, P. M., Wendon, J. A., Gimson, A. E. S., Alexander, G. J. M. & Williams, R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N. Engl. J. Med. 324, 1852–1857 (1991).
Walsh, T. S., Hopton, P., Philips, B. J., Mackenzie, S. J. & Lee, A. The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure. Hepatology 27, 1332–1340 (1998).
Lee, W. M. et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 137, 856–864 (2009).
Kortsalioudaki, C. et al. Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure. Liver Transpl. 14, 25–30 (2008).
Yang, R., Miki, K., He, X., Killeen, M. E. & Fink, M. P. Prolonged treatment with N-acetylcysteine delays liver recovery from acetaminophen hepatotoxicity. Crit. Care doi:10.1186/cc7782.
Jimenez-Saenz, M. & Martinez-Sanchez, C. Green tea extracts and acute liver failure: the need for caution in their use and diagnostic assessment. Liver Transpl. 13, 1067 (2007).
Henderson, N. C. et al. Critical role of c-jun (NH2) terminal kinase in paracetamol-induced acute liver failure. Gut 56, 982–990 (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Riordan, S., Williams, R. Management of non-acetaminophen-induced ALF. Nat Rev Gastroenterol Hepatol 7, 75–77 (2010). https://doi.org/10.1038/nrgastro.2009.236
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2009.236
- Springer Nature Limited